跳转至内容
Merck
  • Investigation of drug-polymer interaction in solid dispersions by vapour sorption methods.

Investigation of drug-polymer interaction in solid dispersions by vapour sorption methods.

International journal of pharmaceutics (2014-04-23)
Kateřina Punčochová, Jerry Y Y Heng, Josef Beránek, František Stěpánek
摘要

The objective of this study was to investigate the effect of different polymeric carriers in solid dispersions with an active pharmaceutical ingredient (API) on their water vapour sorption equilibria and the influence of the API-polymer interactions on the dissolution rate of the API. X-ray diffraction, scanning electron microscopy (SEM), moisture sorption analysis, infrared (IR) spectroscopy and dissolution tests were performed on various API-polymer systems (Valsartan as API with Soluplus, PVP and Eudragit polymers) after production of amorphous solid dispersions by spray drying. The interactions between the API and polymer molecules caused the water sorption isotherms of solid dispersions to deviate from those of ideal mixtures. The moisture sorption isotherms were lower in comparison with the isotherms of physical mixtures in all combinations with Soluplus and PVP. In contrast, the moisture sorption isotherms of solid dispersions containing Eudragit were significantly higher than the corresponding physical mixtures. The nature of the API-polymer interaction was explained by shifts in the characteristic bands of the IR spectra of the solid dispersions compared to the pure components. A correlation between the dissolution rate and the water sorption properties of the API-polymer systems has been established.

材料
货号
品牌
产品描述

Sigma-Aldrich
1-乙烯基-2-吡咯烷酮, contains sodium hydroxide as inhibitor, ≥99%
Sigma-Aldrich
甲基丙烯酸甲酯, contains ≤30 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
2-(二甲氨基)甲基丙烯酸乙酯, contains 700-1000 ppm monomethyl ether hydroquinone as inhibitor, 98%
Sigma-Aldrich
L-赖氨酸 单盐酸盐, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
ε-己内酰胺, 99%
Sigma-Aldrich
甲基丙烯酸丁酯, 99%, contains monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
甲基丙烯酸甲酯, 99%, stabilized
Sigma-Aldrich
L-赖氨酸 单盐酸盐, reagent grade, ≥98% (HPLC)
Supelco
L-赖氨酸 单盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-赖氨酸 单盐酸盐, BioUltra, ≥99.5% (AT)
赖氨酸 盐酸盐, European Pharmacopoeia (EP) Reference Standard
甲基丙烯酸甲酯, European Pharmacopoeia (EP) Reference Standard
Supelco
ε-己内酰胺, analytical standard
Supelco
L-赖氨酸 单盐酸盐, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-赖氨酸盐酸盐 溶液, 100 mM amino acid in 0.1 M HCl, analytical standard
2-(二甲氨基)甲基丙烯酸乙酯, European Pharmacopoeia (EP) Reference Standard
甲基丙烯酸丁酯, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
甲基丙烯酸甲酯, SAJ first grade, ≥99.0%
Sigma-Aldrich
L-赖氨酸 单盐酸盐, SAJ special grade, ≥99.0%